Accession,Organism_Name,Release_Date,Pangolin,PangoVersions,Length,Nuc_Completeness,Protein,Geo_Location,Host,Isolation_Source,Collection_Date
WDB03694.1,Severe acute respiratory syndrome coronavirus 2,2023-02-15T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-11-29
WDB04369.1,Severe acute respiratory syndrome coronavirus 2,2023-02-15T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-12-18
WDB05483.1,Severe acute respiratory syndrome coronavirus 2,2023-02-15T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Bahrain,Homo sapiens,,2023-01-01
WDB09874.1,Severe acute respiratory syndrome coronavirus 2,2023-02-15T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Bahrain,Homo sapiens,,2023-01-29
UZU90993.1,Severe acute respiratory syndrome coronavirus 2,2022-11-24T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-10-26
UZU91975.1,Severe acute respiratory syndrome coronavirus 2,2022-11-24T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-11-06
UZU92431.1,Severe acute respiratory syndrome coronavirus 2,2022-11-24T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-11-07
UZU92524.1,Severe acute respiratory syndrome coronavirus 2,2022-11-24T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-11-09
UYR39716.1,Severe acute respiratory syndrome coronavirus 2,2022-10-27T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-10-16
UYR39976.1,Severe acute respiratory syndrome coronavirus 2,2022-10-27T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-10-16
UYR40012.1,Severe acute respiratory syndrome coronavirus 2,2022-10-27T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-10-16
UYR40024.1,Severe acute respiratory syndrome coronavirus 2,2022-10-27T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-10-16
UYR40329.1,Severe acute respiratory syndrome coronavirus 2,2022-10-27T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-10-16
UYR76496.1,Severe acute respiratory syndrome coronavirus 2,2022-10-27T00:00:00Z,XBB,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-10-24
UXW68809.1,Severe acute respiratory syndrome coronavirus 2,2022-10-05T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-09-29
UXW69057.1,Severe acute respiratory syndrome coronavirus 2,2022-10-05T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-09-29
UXW69080.1,Severe acute respiratory syndrome coronavirus 2,2022-10-05T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-09-30
UWE21679.1,Severe acute respiratory syndrome coronavirus 2,2022-09-06T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,oronasopharynx,2022-08-31
UWE22299.1,Severe acute respiratory syndrome coronavirus 2,2022-09-06T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,oronasopharynx,2022-08-31
UVJ48842.1,Severe acute respiratory syndrome coronavirus 2,2022-08-25T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-08-22
UVJ49140.1,Severe acute respiratory syndrome coronavirus 2,2022-08-25T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-08-23
UVJ49176.1,Severe acute respiratory syndrome coronavirus 2,2022-08-25T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-08-23
UPX44534.1,Severe acute respiratory syndrome coronavirus 2,2022-05-05T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-02-07
UOH86006.1,Severe acute respiratory syndrome coronavirus 2,2022-04-07T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Bahrain,Homo sapiens,,2022-01-25
UZH66932.1,Severe acute respiratory syndrome coronavirus 2,2022-11-10T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1271,complete,surface glycoprotein,China,Homo sapiens,,2022-10-27
UUT03022.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-05-13
UUT03034.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-05-15
UUT03046.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-05-15
UUT03058.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-05-17
UUT03082.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-05-27
UUT03094.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-05-29
UUT03106.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-05-31
UUT03118.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-05-31
UUT03226.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-07-01
UUT03430.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-06-10
UUT03442.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-06-12
UUT03478.1,Severe acute respiratory syndrome coronavirus 2,2022-08-09T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Egypt,Homo sapiens,oronasopharynx,2022-06-16
WCR32811.1,Severe acute respiratory syndrome coronavirus 2,2023-02-09T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,Finland,Homo sapiens,,2022-11-14
WCT80294.1,Severe acute respiratory syndrome coronavirus 2,2023-02-13T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,France,Homo sapiens,oronasopharynx,2022-11-30
WCT80390.1,Severe acute respiratory syndrome coronavirus 2,2023-02-13T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,France,Homo sapiens,oronasopharynx,2022-12-05
WCT80546.1,Severe acute respiratory syndrome coronavirus 2,2023-02-13T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,France,Homo sapiens,oronasopharynx,2022-10-04
WCT80629.1,Severe acute respiratory syndrome coronavirus 2,2023-02-13T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,France,Homo sapiens,oronasopharynx,2022-10-03
WCT80844.1,Severe acute respiratory syndrome coronavirus 2,2023-02-13T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,France,Homo sapiens,oronasopharynx,2022-09-18
UPH85748.1,Severe acute respiratory syndrome coronavirus 2,2022-04-21T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,France,Homo sapiens,oronasopharynx,2022-03-07
WCC89313.1,Severe acute respiratory syndrome coronavirus 2,2023-01-26T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Germany: Hessen,Homo sapiens,,2022-12-19
UZZ65601.1,Severe acute respiratory syndrome coronavirus 2,2022-11-30T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Germany: Hessen,Homo sapiens,,2022-10-05
UZZ66002.1,Severe acute respiratory syndrome coronavirus 2,2022-11-30T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Germany: Hessen,Homo sapiens,,2022-10-13
WBR20219.1,Severe acute respiratory syndrome coronavirus 2,2023-01-12T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,Germany: Rheinland-Pfalz,Homo sapiens,,2022-11-20
WBR20267.1,Severe acute respiratory syndrome coronavirus 2,2023-01-12T00:00:00Z,XBB,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,Germany: Rheinland-Pfalz,Homo sapiens,,2022-11-21
UZZ66026.1,Severe acute respiratory syndrome coronavirus 2,2022-11-30T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Germany: Rheinland-Pfalz,Homo sapiens,,2022-10-13
WCI16196.1,Severe acute respiratory syndrome coronavirus 2,2023-02-01T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,Japan,Homo sapiens,,2022-06-13
BDX23872.1,Severe acute respiratory syndrome coronavirus 2,2023-02-09T00:00:00Z,XBB.1.5,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,Japan: Tokyo,Homo sapiens,,2023-01
BDX23653.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,Japan:Shizuoka,Homo sapiens,"saliva, oronasopharynx",2023-01-26
BDX23677.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Japan:Shizuoka,Homo sapiens,"saliva, oronasopharynx",2023-01-05
BDW80469.1,Severe acute respiratory syndrome coronavirus 2,2023-01-31T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Japan:Shizuoka,Homo sapiens,"saliva, oronasopharynx",2023-01-06
BDX23386.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,"Japan:Shizuoka, Hamamatsu",Homo sapiens,oronasopharynx,2023-01-12
BDU99187.1,Severe acute respiratory syndrome coronavirus 2,2022-12-21T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,"Japan:Shizuoka, center",Homo sapiens,"saliva, oronasopharynx",2022-11-28
BDX14084.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, east",Homo sapiens,oronasopharynx,2022-12-14
BDX14978.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, east",Homo sapiens,oronasopharynx,2022-12-20
BDX15575.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, east",Homo sapiens,oronasopharynx,2022-12-24
BDX15947.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, east",Homo sapiens,oronasopharynx,2022-12-27
BDU97275.1,Severe acute respiratory syndrome coronavirus 2,2022-12-21T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, east",Homo sapiens,oronasopharynx,2022-11-14
BDU97814.1,Severe acute respiratory syndrome coronavirus 2,2022-12-21T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, east",Homo sapiens,oronasopharynx,2022-11-14
BDU48502.1,Severe acute respiratory syndrome coronavirus 2,2022-11-29T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, east",Homo sapiens,oronasopharynx,2022-10-31
BDU48550.1,Severe acute respiratory syndrome coronavirus 2,2022-11-29T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,"Japan:Shizuoka, east",Homo sapiens,oronasopharynx,2022-11-04
BDX14357.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, west",Homo sapiens,"saliva, oronasopharynx",2022-12-19
BDX16781.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, west",Homo sapiens,oronasopharynx,2022-12-27
BDX17020.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,"Japan:Shizuoka, west",Homo sapiens,oronasopharynx,2023-01-04
WAV58735.1,Severe acute respiratory syndrome coronavirus 2,2022-12-20T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1266,complete,surface glycoprotein,Mexico,Homo sapiens,,2022-01-10
WAV61481.1,Severe acute respiratory syndrome coronavirus 2,2022-12-20T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1266,complete,surface glycoprotein,Mexico,Homo sapiens,,2022-01-07
UYE44393.1,Severe acute respiratory syndrome coronavirus 2,2022-10-14T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,New Zealand,Homo sapiens,oronasopharynx,2022-01-15
WAQ63018.1,Severe acute respiratory syndrome coronavirus 2,2022-12-15T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,Nigeria,Homo sapiens,oronasopharynx,2021-12-18
WAS08806.1,Severe acute respiratory syndrome coronavirus 2,2022-12-15T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1273,complete,surface glycoprotein,Russia: Saratov,Homo sapiens,oronasopharynx,2022-09-02
WAS08854.1,Severe acute respiratory syndrome coronavirus 2,2022-12-15T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1273,complete,surface glycoprotein,Russia: Saratov,Homo sapiens,oronasopharynx,2022-09-02
WAS08890.1,Severe acute respiratory syndrome coronavirus 2,2022-12-15T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1273,complete,surface glycoprotein,Russia: Saratov,Homo sapiens,oronasopharynx,2022-11-25
WAS08902.1,Severe acute respiratory syndrome coronavirus 2,2022-12-15T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1273,complete,surface glycoprotein,Russia: Saratov,Homo sapiens,oronasopharynx,2022-11-25
WCD45032.1,Severe acute respiratory syndrome coronavirus 2,2023-01-27T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,South Africa: Northern Cape,Homo sapiens,,2022-11-18
UZR07745.1,Severe acute respiratory syndrome coronavirus 2,2022-11-21T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,South Africa: Western Cape,Homo sapiens,,2022-10-07
UZR08283.1,Severe acute respiratory syndrome coronavirus 2,2022-11-21T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,South Africa: Western Cape,Homo sapiens,,2022-10-17
WDR26260.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA,Homo sapiens,,2023-01-22
WDR26611.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2023-01-23
WDR28604.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2023-02-08
WDR28772.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA,Homo sapiens,,2023-01-16
WDR28851.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2023-02-11
WDR29075.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2023-02-01
WDR29280.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,XBB.1.5,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA,Homo sapiens,,2023-01-21
WDR29504.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2023-01-19
WDR29617.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2023-02-07
WDR30486.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2023-02-03
WDR31537.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2023-02-09
WDR31605.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2023-02-04
WDR31685.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2023-02-08
WCK80516.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,XBF,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2023-01-18
WCK80655.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2023-01-19
WCK80726.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2023-01-13
WBP75284.1,Severe acute respiratory syndrome coronavirus 2,2023-01-10T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2022-12-11
WBP75308.1,Severe acute respiratory syndrome coronavirus 2,2023-01-10T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2022-12-14
WBP75415.1,Severe acute respiratory syndrome coronavirus 2,2023-01-10T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2022-12-08
WBP75666.1,Severe acute respiratory syndrome coronavirus 2,2023-01-10T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2022-12-16
WBD90187.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA,Homo sapiens,,2022-12-06
WBD91357.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA,Homo sapiens,,2022-11-28
WBD91939.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-11-30
WBD92483.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-11-22
UTH86129.1,Severe acute respiratory syndrome coronavirus 2,2022-07-12T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-05-31
UTH86211.1,Severe acute respiratory syndrome coronavirus 2,2022-07-12T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-05-23
UTH86306.1,Severe acute respiratory syndrome coronavirus 2,2022-07-12T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-05-12
UTH86341.1,Severe acute respiratory syndrome coronavirus 2,2022-07-12T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-06-06
UTH86493.1,Severe acute respiratory syndrome coronavirus 2,2022-07-12T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-06-06
UMM71320.1,Severe acute respiratory syndrome coronavirus 2,2022-03-03T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-02-01
UMM71427.1,Severe acute respiratory syndrome coronavirus 2,2022-03-03T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1272,complete,surface glycoprotein,USA,Homo sapiens,,2022-02-11
UMM71915.1,Severe acute respiratory syndrome coronavirus 2,2022-03-03T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1275,complete,surface glycoprotein,USA,Homo sapiens,,2022-01-31
UMM71999.1,Severe acute respiratory syndrome coronavirus 2,2022-03-03T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-01-18
UMM72418.1,Severe acute respiratory syndrome coronavirus 2,2022-03-03T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1275,complete,surface glycoprotein,USA,Homo sapiens,,2022-01-18
UMM72802.1,Severe acute respiratory syndrome coronavirus 2,2022-03-03T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA,Homo sapiens,,2022-01-31
WBV16150.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-09
WBV16243.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-09
WBV16301.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-09
WBV16408.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-09
WBV16586.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-09
WBV17943.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-10
WBV18105.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-10
WBV18268.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-10
WBV18579.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-10
WBV18663.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2023-01-10
WBT85306.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-30
WBT85390.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-30
WBT85450.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-30
WBR07558.1,Severe acute respiratory syndrome coronavirus 2,2023-01-12T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-29
WBR07582.1,Severe acute respiratory syndrome coronavirus 2,2023-01-12T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-29
WBR07713.1,Severe acute respiratory syndrome coronavirus 2,2023-01-12T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-29
WBR08293.1,Severe acute respiratory syndrome coronavirus 2,2023-01-12T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-29
WBR08846.1,Severe acute respiratory syndrome coronavirus 2,2023-01-12T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-29
WBP38496.1,Severe acute respiratory syndrome coronavirus 2,2023-01-10T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-18
WBP38745.1,Severe acute respiratory syndrome coronavirus 2,2023-01-10T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-18
WBP38889.1,Severe acute respiratory syndrome coronavirus 2,2023-01-10T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-18
WBP43116.1,Severe acute respiratory syndrome coronavirus 2,2023-01-10T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-22
WBP43486.1,Severe acute respiratory syndrome coronavirus 2,2023-01-10T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-22
WBC64135.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-07
WBC68841.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WBC69174.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WBC69222.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WBC69617.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WBC69677.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WBC78819.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-09
WBC79741.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-10
WBC79753.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-10
WBC79933.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-10
WAY59092.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-02
WAY59128.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-02
WAY59316.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-02
WAY60428.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-03
WAY60572.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-03
WAY60608.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-03
WAY60704.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-03
WAY61051.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-03
WAY61111.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-03
WAY61134.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,XBB,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-03
WAY61169.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-03
WAY61241.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-03
WAX27531.1,Severe acute respiratory syndrome coronavirus 2,2022-12-22T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WAX27543.1,Severe acute respiratory syndrome coronavirus 2,2022-12-22T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WAX27579.1,Severe acute respiratory syndrome coronavirus 2,2022-12-22T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WAX27603.1,Severe acute respiratory syndrome coronavirus 2,2022-12-22T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WAX27794.1,Severe acute respiratory syndrome coronavirus 2,2022-12-22T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WAX27818.1,Severe acute respiratory syndrome coronavirus 2,2022-12-22T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-08
WAX31877.1,Severe acute respiratory syndrome coronavirus 2,2022-12-22T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-09
WAX31901.1,Severe acute respiratory syndrome coronavirus 2,2022-12-22T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-09
WAX31936.1,Severe acute respiratory syndrome coronavirus 2,2022-12-22T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: California,Homo sapiens,oronasopharynx,2022-12-09
WBC71802.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-12-09
WBC74029.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-12-09
WBC74352.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-12-09
WBC75344.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-12-09
WBC76813.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-12-09
UZD87554.1,Severe acute respiratory syndrome coronavirus 2,2022-11-07T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-10-21
UZD87638.1,Severe acute respiratory syndrome coronavirus 2,2022-11-07T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-10-21
UZD87971.1,Severe acute respiratory syndrome coronavirus 2,2022-11-07T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-10-21
UZD88210.1,Severe acute respiratory syndrome coronavirus 2,2022-11-07T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-10-21
UZD88546.1,Severe acute respiratory syndrome coronavirus 2,2022-11-07T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Florida,Homo sapiens,oronasopharynx,2022-10-22
WDG19927.1,Severe acute respiratory syndrome coronavirus 2,2023-02-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: GA,Homo sapiens,,2023-01-27
WCN87220.1,Severe acute respiratory syndrome coronavirus 2,2023-02-06T00:00:00Z,XBB.1.5,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: GA,Homo sapiens,,2023-01-11
WCF43554.1,Severe acute respiratory syndrome coronavirus 2,2023-01-30T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: GA,Homo sapiens,,2022-12-28
WCF43577.1,Severe acute respiratory syndrome coronavirus 2,2023-01-30T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: GA,Homo sapiens,,2023-01-02
WCF43660.1,Severe acute respiratory syndrome coronavirus 2,2023-01-30T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: GA,Homo sapiens,,2023-01-03
WCF43828.1,Severe acute respiratory syndrome coronavirus 2,2023-01-30T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: GA,Homo sapiens,,2023-01-10
WCF43910.1,Severe acute respiratory syndrome coronavirus 2,2023-01-30T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: GA,Homo sapiens,,2023-01-07
UYC41960.1,Severe acute respiratory syndrome coronavirus 2,2022-10-12T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Georgia,Homo sapiens,oronasopharynx,2022-09-30
UYC42638.1,Severe acute respiratory syndrome coronavirus 2,2022-10-12T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Georgia,Homo sapiens,oronasopharynx,2022-09-30
UUM84368.1,Severe acute respiratory syndrome coronavirus 2,2022-08-07T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Georgia,Homo sapiens,oronasopharynx,2022-07-27
UQF88950.1,Severe acute respiratory syndrome coronavirus 2,2022-05-10T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Georgia,Homo sapiens,oronasopharynx,2022-04-20
WCP39923.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Hawaii,Homo sapiens,oronasopharynx,2023-01-26
WAE01770.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-11-16
WAE02189.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-11-16
WAE05619.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-11-16
WAE05715.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-11-17
WAA29605.1,Severe acute respiratory syndrome coronavirus 2,2022-12-01T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-11-16
UYN26851.1,Severe acute respiratory syndrome coronavirus 2,2022-10-24T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-10-09
UYN27824.1,Severe acute respiratory syndrome coronavirus 2,2022-10-24T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-10-10
UYN42781.1,Severe acute respiratory syndrome coronavirus 2,2022-10-24T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-10-10
UYN43889.1,Severe acute respiratory syndrome coronavirus 2,2022-10-24T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-10-10
UYL60593.1,Severe acute respiratory syndrome coronavirus 2,2022-10-21T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-10-05
UYI50744.1,Severe acute respiratory syndrome coronavirus 2,2022-10-19T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-10-04
UYI51926.1,Severe acute respiratory syndrome coronavirus 2,2022-10-19T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-10-05
UYI52356.1,Severe acute respiratory syndrome coronavirus 2,2022-10-19T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-10-05
UYI53061.1,Severe acute respiratory syndrome coronavirus 2,2022-10-19T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Illinois,Homo sapiens,oronasopharynx,2022-10-06
WBG24840.1,Severe acute respiratory syndrome coronavirus 2,2023-01-04T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Indiana,Homo sapiens,oronasopharynx,2022-12-13
WBG25900.1,Severe acute respiratory syndrome coronavirus 2,2023-01-04T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Indiana,Homo sapiens,oronasopharynx,2022-12-14
WBG27069.1,Severe acute respiratory syndrome coronavirus 2,2023-01-04T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Indiana,Homo sapiens,oronasopharynx,2022-12-15
WBG27198.1,Severe acute respiratory syndrome coronavirus 2,2023-01-04T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Indiana,Homo sapiens,oronasopharynx,2022-12-15
WBG30145.1,Severe acute respiratory syndrome coronavirus 2,2023-01-04T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Indiana,Homo sapiens,oronasopharynx,2022-12-16
WBK31225.1,Severe acute respiratory syndrome coronavirus 2,2023-01-06T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Kansas,Homo sapiens,oronasopharynx,2022-12-17
WBK32409.1,Severe acute respiratory syndrome coronavirus 2,2023-01-06T00:00:00Z,XBF,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Kansas,Homo sapiens,oronasopharynx,2022-12-19
WBK33685.1,Severe acute respiratory syndrome coronavirus 2,2023-01-06T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Kansas,Homo sapiens,oronasopharynx,2022-12-20
WAN24125.1,Severe acute respiratory syndrome coronavirus 2,2022-12-12T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Kansas,Homo sapiens,oronasopharynx,2022-11-27
WAL15111.1,Severe acute respiratory syndrome coronavirus 2,2022-12-09T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Kansas,Homo sapiens,oronasopharynx,2022-11-16
WAL17045.1,Severe acute respiratory syndrome coronavirus 2,2022-12-09T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Kansas,Homo sapiens,oronasopharynx,2022-11-17
UZY27429.1,Severe acute respiratory syndrome coronavirus 2,2022-11-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Kansas,Homo sapiens,oronasopharynx,2022-11-13
UYH80812.1,Severe acute respiratory syndrome coronavirus 2,2022-10-18T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Nebraska,Homo sapiens,oronasopharynx,2022-09-30
UYG74199.1,Severe acute respiratory syndrome coronavirus 2,2022-10-17T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Nebraska,Homo sapiens,oronasopharynx,2022-09-23
WDE61338.1,Severe acute respiratory syndrome coronavirus 2,2023-02-17T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Nevada,Homo sapiens,oronasopharynx,2023-02-03
WDE62692.1,Severe acute respiratory syndrome coronavirus 2,2023-02-17T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Nevada,Homo sapiens,oronasopharynx,2023-02-03
WDD85524.1,Severe acute respiratory syndrome coronavirus 2,2023-02-16T00:00:00Z,XBF,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Nevada,Homo sapiens,oronasopharynx,2023-02-01
WCC27216.1,Severe acute respiratory syndrome coronavirus 2,2023-01-26T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Nevada,Homo sapiens,oronasopharynx,2023-01-06
WCC31975.1,Severe acute respiratory syndrome coronavirus 2,2023-01-26T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Nevada,Homo sapiens,oronasopharynx,2023-01-07
WCC35457.1,Severe acute respiratory syndrome coronavirus 2,2023-01-26T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Nevada,Homo sapiens,oronasopharynx,2023-01-08
UYH97671.1,Severe acute respiratory syndrome coronavirus 2,2022-10-18T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New Hampshire,Homo sapiens,oronasopharynx,2022-10-08
UYF47304.1,Severe acute respiratory syndrome coronavirus 2,2022-10-17T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: New Hampshire,Homo sapiens,oronasopharynx,2022-10-01
UXR18141.1,Severe acute respiratory syndrome coronavirus 2,2022-10-04T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New Hampshire,Homo sapiens,oronasopharynx,2022-09-15
UXH22859.1,Severe acute respiratory syndrome coronavirus 2,2022-09-24T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: New Hampshire,Homo sapiens,oronasopharynx,2022-09-12
WCK00341.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: New Jersey,Homo sapiens,oronasopharynx,2023-01-16
WCK00580.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: New Jersey,Homo sapiens,oronasopharynx,2023-01-16
WCF95604.1,Severe acute respiratory syndrome coronavirus 2,2023-01-31T00:00:00Z,XBB.1.5,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: New Jersey,Homo sapiens,oronasopharynx,2023-01-20
WCG99939.1,Severe acute respiratory syndrome coronavirus 2,2023-01-31T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New Jersey,Homo sapiens,oronasopharynx,2023-01-12
WCC25996.1,Severe acute respiratory syndrome coronavirus 2,2023-01-26T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2023-01-06
WCC27328.1,Severe acute respiratory syndrome coronavirus 2,2023-01-26T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2023-01-06
WCC28714.1,Severe acute respiratory syndrome coronavirus 2,2023-01-26T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2023-01-07
WCC29507.1,Severe acute respiratory syndrome coronavirus 2,2023-01-26T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2023-01-07
WCC35011.1,Severe acute respiratory syndrome coronavirus 2,2023-01-26T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2023-01-08
WBA75123.1,Severe acute respiratory syndrome coronavirus 2,2022-12-27T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-12-16
WBA75519.1,Severe acute respiratory syndrome coronavirus 2,2022-12-27T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-12-16
WAY07133.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-12-09
WAU57206.1,Severe acute respiratory syndrome coronavirus 2,2022-12-20T00:00:00Z,XBB,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-12-03
WAU58654.1,Severe acute respiratory syndrome coronavirus 2,2022-12-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-12-03
WAU58794.1,Severe acute respiratory syndrome coronavirus 2,2022-12-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-12-03
WAU59488.1,Severe acute respiratory syndrome coronavirus 2,2022-12-20T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-12-03
WAU61763.1,Severe acute respiratory syndrome coronavirus 2,2022-12-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-12-04
WAU62194.1,Severe acute respiratory syndrome coronavirus 2,2022-12-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-12-04
WAP45725.1,Severe acute respiratory syndrome coronavirus 2,2022-12-14T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-11-28
WAP46714.1,Severe acute respiratory syndrome coronavirus 2,2022-12-14T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-11-29
WAP46844.1,Severe acute respiratory syndrome coronavirus 2,2022-12-14T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-11-29
WAD99915.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-11-16
WAE00609.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-11-16
WAE00729.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-11-16
WAE02129.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-11-16
WAE02344.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: New York,Homo sapiens,oronasopharynx,2022-11-16
WBY82211.1,Severe acute respiratory syndrome coronavirus 2,2023-01-24T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2023-01-12
WBY83969.1,Severe acute respiratory syndrome coronavirus 2,2023-01-24T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2023-01-13
WBY87047.1,Severe acute respiratory syndrome coronavirus 2,2023-01-24T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2023-01-15
WBX04670.1,Severe acute respiratory syndrome coronavirus 2,2023-01-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2023-01-02
WBX04742.1,Severe acute respiratory syndrome coronavirus 2,2023-01-23T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2023-01-02
WBX06184.1,Severe acute respiratory syndrome coronavirus 2,2023-01-23T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2023-01-03
WAY09761.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2022-12-10
WAY11065.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2022-12-11
WAY11275.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2022-12-11
WAY11499.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2022-12-11
WAY12713.1,Severe acute respiratory syndrome coronavirus 2,2022-12-23T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2022-12-12
UYH69558.1,Severe acute respiratory syndrome coronavirus 2,2022-10-18T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2022-10-05
UYH69570.1,Severe acute respiratory syndrome coronavirus 2,2022-10-18T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2022-10-05
UYH80254.1,Severe acute respiratory syndrome coronavirus 2,2022-10-18T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2022-09-30
UYH85583.1,Severe acute respiratory syndrome coronavirus 2,2022-10-18T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: North Carolina,Homo sapiens,oronasopharynx,2022-10-02
WBW67662.1,Severe acute respiratory syndrome coronavirus 2,2023-01-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1271,complete,surface glycoprotein,"USA: Oklahoma, Tuttle",Homo sapiens,,2023-01-01
WBW66484.1,Severe acute respiratory syndrome coronavirus 2,2023-01-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,"USA: Oklahoma, Yukon",Homo sapiens,,2023-01-03
WBW68409.1,Severe acute respiratory syndrome coronavirus 2,2023-01-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1271,complete,surface glycoprotein,"USA: Oklahoma, Yukon",Homo sapiens,,2023-01-02
WDG03461.1,Severe acute respiratory syndrome coronavirus 2,2023-02-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Oregon,Homo sapiens,,2023-02-04
WAJ10934.1,Severe acute respiratory syndrome coronavirus 2,2022-12-07T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Oregon,Homo sapiens,,2022-11-25
WAJ11006.1,Severe acute respiratory syndrome coronavirus 2,2022-12-07T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Oregon,Homo sapiens,,2022-11-25
WAJ11078.1,Severe acute respiratory syndrome coronavirus 2,2022-12-07T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Oregon,Homo sapiens,,2022-11-26
WAD84522.1,Severe acute respiratory syndrome coronavirus 2,2022-12-05T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Oregon,Homo sapiens,oronasopharynx,2022-11-21
UZT30461.1,Severe acute respiratory syndrome coronavirus 2,2022-11-22T00:00:00Z,XBB,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: Oregon,Homo sapiens,oronasopharynx,2022-11-03
UZI07566.1,Severe acute respiratory syndrome coronavirus 2,2022-11-11T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Oregon,Homo sapiens,oronasopharynx,2022-10-26
UZI07683.1,Severe acute respiratory syndrome coronavirus 2,2022-11-11T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Oregon,Homo sapiens,oronasopharynx,2022-10-26
WCJ04499.1,Severe acute respiratory syndrome coronavirus 2,2023-02-02T00:00:00Z,XBB.1.5,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2023-01-20
WCH79891.1,Severe acute respiratory syndrome coronavirus 2,2023-02-01T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2023-01-17
WCH00467.1,Severe acute respiratory syndrome coronavirus 2,2023-01-31T00:00:00Z,XBB.1.5,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2023-01-12
WCE17926.1,Severe acute respiratory syndrome coronavirus 2,2023-01-29T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2023-01-15
WCD74580.1,Severe acute respiratory syndrome coronavirus 2,2023-01-28T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2023-01-15
WCD48586.1,Severe acute respiratory syndrome coronavirus 2,2023-01-27T00:00:00Z,XBB.1.5,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2023-01-07
WBR99167.1,Severe acute respiratory syndrome coronavirus 2,2023-01-15T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2023-01-05
WBR99693.1,Severe acute respiratory syndrome coronavirus 2,2023-01-15T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2023-01-05
WBR41082.1,Severe acute respiratory syndrome coronavirus 2,2023-01-13T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2022-12-26
WBR41828.1,Severe acute respiratory syndrome coronavirus 2,2023-01-13T00:00:00Z,XBB.1.5,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2022-12-26
WBR42232.1,Severe acute respiratory syndrome coronavirus 2,2023-01-13T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2022-12-27
WAM96170.1,Severe acute respiratory syndrome coronavirus 2,2022-12-12T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2022-11-29
WAM99543.1,Severe acute respiratory syndrome coronavirus 2,2022-12-12T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2022-11-22
WAN01381.1,Severe acute respiratory syndrome coronavirus 2,2022-12-12T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2022-11-23
WAN02053.1,Severe acute respiratory syndrome coronavirus 2,2022-12-12T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Pennsylvania,Homo sapiens,oronasopharynx,2022-11-23
WDR16176.1,Severe acute respiratory syndrome coronavirus 2,2023-02-23T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Tennessee,Homo sapiens,oronasopharynx,2023-02-10
WDG24982.1,Severe acute respiratory syndrome coronavirus 2,2023-02-21T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Tennessee,Homo sapiens,oronasopharynx,2023-02-08
WDL07646.1,Severe acute respiratory syndrome coronavirus 2,2023-02-21T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Tennessee,Homo sapiens,oronasopharynx,2023-02-05
WDL14625.1,Severe acute respiratory syndrome coronavirus 2,2023-02-21T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Tennessee,Homo sapiens,oronasopharynx,2023-02-06
WCZ43594.1,Severe acute respiratory syndrome coronavirus 2,2023-02-13T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Tennessee,Homo sapiens,oronasopharynx,2023-01-25
WCZ43916.1,Severe acute respiratory syndrome coronavirus 2,2023-02-13T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Tennessee,Homo sapiens,oronasopharynx,2023-01-25
WBW77111.1,Severe acute respiratory syndrome coronavirus 2,2023-01-20T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-30
WBW77123.1,Severe acute respiratory syndrome coronavirus 2,2023-01-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-30
WBW82022.1,Severe acute respiratory syndrome coronavirus 2,2023-01-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2023-01-02
WBW82188.1,Severe acute respiratory syndrome coronavirus 2,2023-01-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2023-01-02
WBW82332.1,Severe acute respiratory syndrome coronavirus 2,2023-01-20T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2023-01-02
WBE78819.1,Severe acute respiratory syndrome coronavirus 2,2023-01-03T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-11
WBE78999.1,Severe acute respiratory syndrome coronavirus 2,2023-01-03T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-11
WBE80139.1,Severe acute respiratory syndrome coronavirus 2,2023-01-03T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-12
WBC96463.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-12
WBC96888.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-12
WBC97210.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-12
WBC97258.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-12
WBC97414.1,Severe acute respiratory syndrome coronavirus 2,2022-12-29T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-12-12
WAT73958.1,Severe acute respiratory syndrome coronavirus 2,2022-12-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-11-29
WAT74065.1,Severe acute respiratory syndrome coronavirus 2,2022-12-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-11-29
WAT74281.1,Severe acute respiratory syndrome coronavirus 2,2022-12-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-11-29
UYN42147.1,Severe acute respiratory syndrome coronavirus 2,2022-10-24T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-10-10
UYN45407.1,Severe acute respiratory syndrome coronavirus 2,2022-10-24T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-10-10
UYN45562.1,Severe acute respiratory syndrome coronavirus 2,2022-10-24T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Texas,Homo sapiens,oronasopharynx,2022-10-10
WCL44885.1,Severe acute respiratory syndrome coronavirus 2,2023-02-04T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Utah,Homo sapiens,oronasopharynx,2023-01-17
WCD69470.1,Severe acute respiratory syndrome coronavirus 2,2023-01-28T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Utah,Homo sapiens,oronasopharynx,2023-01-07
WCD49161.1,Severe acute respiratory syndrome coronavirus 2,2023-01-27T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Utah,Homo sapiens,oronasopharynx,2023-01-08
WBY82630.1,Severe acute respiratory syndrome coronavirus 2,2023-01-24T00:00:00Z,XBF,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2023-01-13
WBY83356.1,Severe acute respiratory syndrome coronavirus 2,2023-01-24T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2023-01-13
WBS39550.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2023-01-05
WBS40112.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2023-01-06
WBS40468.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2023-01-06
WBT72909.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2023-01-03
WBT72943.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2023-01-03
WBT73486.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2023-01-03
WAH82476.1,Severe acute respiratory syndrome coronavirus 2,2022-12-06T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2022-11-21
WAH83783.1,Severe acute respiratory syndrome coronavirus 2,2022-12-06T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2022-11-22
WAH84711.1,Severe acute respiratory syndrome coronavirus 2,2022-12-06T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Virginia,Homo sapiens,oronasopharynx,2022-11-22
WDP82304.1,Severe acute respiratory syndrome coronavirus 2,2023-02-22T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-02-07
WDP82550.1,Severe acute respiratory syndrome coronavirus 2,2023-02-22T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-02-08
WDP82842.1,Severe acute respiratory syndrome coronavirus 2,2023-02-22T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-02-08
WDP83214.1,Severe acute respiratory syndrome coronavirus 2,2023-02-22T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-02-10
WDP83344.1,Severe acute respiratory syndrome coronavirus 2,2023-02-22T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Washington,Homo sapiens,,2023-02-10
WCP27322.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Washington,Homo sapiens,,2023-01-20
WCP27458.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-23
WCP27621.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,XBF,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-23
WCP27680.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-23
WCP27962.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-23
WCP28293.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,XBB.1.5,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-24
WCP28305.1,Severe acute respiratory syndrome coronavirus 2,2023-02-08T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-24
WCF85191.1,Severe acute respiratory syndrome coronavirus 2,2023-01-31T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-10
WCF02585.1,Severe acute respiratory syndrome coronavirus 2,2023-01-30T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-13
WCD69263.1,Severe acute respiratory syndrome coronavirus 2,2023-01-28T00:00:00Z,XBB,4.2/1.18.1.1/v0.1.10/0.3.17,1269,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-06
WCD69563.1,Severe acute respiratory syndrome coronavirus 2,2023-01-28T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2023-01-07
WCD37144.1,Severe acute respiratory syndrome coronavirus 2,2023-01-27T00:00:00Z,XBF,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2022-12-22
WCD37347.1,Severe acute respiratory syndrome coronavirus 2,2023-01-27T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2022-12-22
WCD37383.1,Severe acute respiratory syndrome coronavirus 2,2023-01-27T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2022-12-22
WCD37407.1,Severe acute respiratory syndrome coronavirus 2,2023-01-27T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2022-12-22
WCD37467.1,Severe acute respiratory syndrome coronavirus 2,2023-01-27T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2022-12-22
WAJ12069.1,Severe acute respiratory syndrome coronavirus 2,2022-12-07T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2022-11-28
WAJ12225.1,Severe acute respiratory syndrome coronavirus 2,2022-12-07T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2022-11-28
WAJ12367.1,Severe acute respiratory syndrome coronavirus 2,2022-12-07T00:00:00Z,XBF,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2022-11-28
WAJ12821.1,Severe acute respiratory syndrome coronavirus 2,2022-12-07T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Washington,Homo sapiens,oronasopharynx,2022-11-28
WCO57366.1,Severe acute respiratory syndrome coronavirus 2,2023-02-07T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: West Virginia,Homo sapiens,,2022-11-17
WCO57413.1,Severe acute respiratory syndrome coronavirus 2,2023-02-07T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: West Virginia,Homo sapiens,,2022-11-18
WCO57576.1,Severe acute respiratory syndrome coronavirus 2,2023-02-07T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: West Virginia,Homo sapiens,,2022-11-17
WCO57826.1,Severe acute respiratory syndrome coronavirus 2,2023-02-07T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: West Virginia,Homo sapiens,,2022-11-30
WCO57898.1,Severe acute respiratory syndrome coronavirus 2,2023-02-07T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: West Virginia,Homo sapiens,,2022-11-17
WBV05986.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: West Virginia,Homo sapiens,oronasopharynx,2023-01-05
WBV08043.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,CH.1.1,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: West Virginia,Homo sapiens,oronasopharynx,2023-01-05
WBV09241.1,Severe acute respiratory syndrome coronavirus 2,2023-01-19T00:00:00Z,BQ.1,4.2/1.18.1.1/v0.1.10/0.3.17,1267,complete,surface glycoprotein,USA: West Virginia,Homo sapiens,oronasopharynx,2023-01-06
UYZ54557.1,Severe acute respiratory syndrome coronavirus 2,2022-11-03T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Wisconsin,Homo sapiens,oronasopharynx,2022-10-20
UTV24054.1,Severe acute respiratory syndrome coronavirus 2,2022-07-23T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Wisconsin,Homo sapiens,oronasopharynx,2022-07-10
UTI21415.1,Severe acute respiratory syndrome coronavirus 2,2022-07-12T00:00:00Z,BA.2.75,4.2/1.18.1.1/v0.1.10/0.3.17,1270,complete,surface glycoprotein,USA: Wisconsin,Homo sapiens,oronasopharynx,2022-06-23
WBS27069.1,Severe acute respiratory syndrome coronavirus 2,2023-01-17T00:00:00Z,BF.7,4.2/1.18.1.1/v0.1.10/0.3.17,1268,complete,surface glycoprotein,USA: Wyoming,Homo sapiens,oronasopharynx,2022-12-29
UYW62681.1,Severe acute respiratory syndrome coronavirus 2,2022-11-01T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1271,complete,surface glycoprotein,Viet Nam,Homo sapiens,oronasopharynx,2022-08-16
UYW64158.1,Severe acute respiratory syndrome coronavirus 2,2022-11-01T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1271,complete,surface glycoprotein,Viet Nam,Homo sapiens,oronasopharynx,2022-08-29
UPP30651.1,Severe acute respiratory syndrome coronavirus 2,2022-04-28T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1273,complete,surface glycoprotein,West Bank: Jerusalem,Homo sapiens,oronasopharynx,2022-01-09
UPP30840.1,Severe acute respiratory syndrome coronavirus 2,2022-04-28T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1273,complete,surface glycoprotein,West Bank: Ramallah,Homo sapiens,oronasopharynx,2022-01-18
UPP30924.1,Severe acute respiratory syndrome coronavirus 2,2022-04-28T00:00:00Z,B.1.1.529,4.2/1.18.1.1/v0.1.10/0.3.17,1273,complete,surface glycoprotein,West Bank: Ramallah,Homo sapiens,oronasopharynx,2022-01-12
